AIP
BIOA

Ameritas Investment Partners’s BioAge Labs BIOA Stock Holding History

Ameritas Investment Partners’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.2K Buy
2,470
+1,201
+95% +$23.1K ﹤0.01% 2173
2025
Q4 		$16.8K Hold
1,269
– – ﹤0.01% 2714
2025
Q3 		$7.46K Hold
1,269
– – ﹤0.01% 3001
2025
Q2 		$5.24K Hold
1,269
– – ﹤0.01% 3103
2025
Q1 		$4.77K Hold
1,269
– – ﹤0.01% 2980
2024
Q4 		$7.35K Buy
+1,269
New +$21.9K ﹤0.01% 2977

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Ameritas Investment Partners's BIOA Position: Q1 2026 in Review

Ameritas Investment Partners increased its BioAge Labs (BIOA) stake by 95% in Q1 2026, buying an estimated $23.1K and bringing the position to 2,470 shares worth $43.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2173.

Ameritas Investment Partners first reported a position in BIOA in Q4 2024 and has held it in 6 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Ameritas Investment Partners held 2,470 shares of BioAge Labs worth $43.2K as of Q1 2026.
  • Ameritas Investment Partners bought 1,201 BioAge Labs shares in Q1 2026, an estimated $23.1K.
  • BioAge Labs made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2173 holding.
  • Ameritas Investment Partners first reported a position in BioAge Labs in Q4 2024 and has held it in 6 quarters since.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.